News

Longboard Pharmaceuticals to Participate in Three Upcoming Investor Conferences

LA JOLLA, Calif.–(BUSINESS WIRE)—- $LBPH #Epilepsy–Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that members of its senior management team will participate in […]


ADVERTISEMENT — Advertise With Biotech Networks
News

NEURELIS TO PRESENT ANALYSES OF VALTOCO® (diazepam nasal spray) CIV HIGHLIGHTING EFFECTS ON TIMING OF SEIZURES AT THE 35TH INTERNATIONAL EPILEPSY CONGRESS

Data presented will include: SEIzure InterVAL (SEIVAL), the time between clusters Association between time to treatment and associated seizure cessation and duration SAN DIEGO, Aug. 31, 2023 /PRNewswire/ — Neurelis, Inc. will present additional clinical […]

News

Avidity Biosciences Announces Upcoming Presentations at 2023 Myotonic Dystrophy Foundation Annual Conference

SAN DIEGO, Aug. 31, 2023 /PRNewswire/ — Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that the company will […]

News

CalciMedica to Host Acute Pancreatitis Clinical Experts Event on September 21, 2023

LA JOLLA, Calif., Aug. 31, 2023 /PRNewswire/ — CalciMedica Inc. (“CalciMedica”) (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic… […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Equillium to Attend Wells Fargo Healthcare Conference & Present at H.C. Wainwright 25th Annual Global Investor Conference

LA JOLLA, Calif.–(BUSINESS WIRE)—- $EQ–Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that it will host […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Portugal’s Health Systems Achieve Breakthrough with PrecisePK’s Bayesian Precision Dosing, Pioneering Personalized Care

SAN DIEGO, Aug. 30, 2023 /PRNewswire/ — Today, PrecisePK announces that it has been selected by Portugal’s top health system, Luisadas Saude Health (LSHS), to implement the Bayesian precision dosing technology for optimized clinical outcomes. […]

News

NuVasive to Participate as Double Diamond Sponsor at Scoliosis Research Society Annual Meeting

SAN DIEGO, Aug. 30, 2023 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will continue its partnership […]


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks
News

Scale Biosciences Continues Commercial Expansion with Introduction of New and Differentiated Single Cell Methylation and Single Cell RNA Sequencing Solutions

SAN DIEGO–(BUSINESS WIRE)–Scale Biosciences announces new and differentiated single cell methylation and single cell RNA sequencing solutions. Click here to view original post

News

Halozyme Announces Approval of Roche’s Tecentriq® Subcutaneous (SC) with ENHANZE® in Great Britain

First subcutaneous anti-PD-(L)1 cancer immunotherapy available to patients in Great Britain Tecentriq® subcutaneous formulation with ENHANZE® reduces treatment time to seven minutes compared to 30-60 minutes for standard intravenous infusion SAN DIEGO, Aug. 29, 2023 […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Medical Innovator, Cellmyx Inc., Receives Health Canada MDL Clearance for Revolutionary intelliFat® BOD™ Technology

CARLSBAD, Calif., Aug. 28, 2023 /PRNewswire/ — Cellmyx Inc., a pioneering medical technologies company known for its commitment to advancing cosmetic surgery and regenerative medicine, is excited to announce the Health Canada Medical Device License […]

News

Neurocrine Biosciences Presents New INGREZZA® (valbenazine) Capsules Data Demonstrating Early and Sustained Improvements in Chorea Associated With Huntington’s Disease

Data Presented at the 2023 MDS International Congress of Parkinson’s Disease and Movement Disorders® SAN DIEGO, Aug. 28, 2023 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced new data on now FDA-approved INGREZZA® (valbenazine) […]


ADVERTISEMENT — Advertise With Biotech Networks